ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293917/mblSNPs2_CAM.vcf.gzftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293918/mblSNPs2_BUD.vcf.gzftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293917/mblSNPs2_CAM.vcf.csiftp://ftp.sra.ebi.ac.uk/vol1/analysis/ERZ162/ERZ16293918/mblSNPs2_BUD.vcf.csiprimaryOK200GenomicsDepartment of Internal Medicine and Hematology, Semmelweis UniversityEuropean Bioinformatics Institutehttps://www.ebi.ac.uk/ena/browser/view/PRJEB60441EBIHomo sapiensxref:EuropePMC:PMC10084477Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroupsENAfalseRole of the complement lectin pathway activation in COVID-19 disease severity2023-03-172023-03-09PRJEB604419606